ORGNW: the balance sheet

MyFinsight

For the quarter ending 2026-03-31, ORGNW has $135,075K in assets. $46,755K in debts. $19,191K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
265.61%
Quick Ratio
262.03%
Cash Ratio
100.88%
Debt to Asset Ratio
34.61%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Land held for sale
Operating lease right-of-use ass...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Canadian government research and...
Others

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Cash and cash equivalents	19,191	32,923	34,061	35,295
Marketable securities	13,457	20,545	20,279	34,106
Accounts receivable net of allowance for credit losses of 5,448 and 828, respectively	5,362	13,049	15,534	17,888
Other receivables	1,587	2,101	2,456	2,661
Inventory	682	684	635	687
Prepaid expenses and other current assets	1,126	2,448	2,045	1,833
Land held for sale	9,125	9,126	9,125	9,114
Total current assets	50,530	80,876	84,135	101,584
Property, plant, and equipment, net	79,726	72,852	225,744	229,068
Operating lease right-of-use asset	3,080	3,149	3,270	3,357
Intangible assets, net	24	32	51	60
Deferred tax assets	-	0	410	496
Other long-term assets	1,715	751	13,735	13,812
Total assets	135,075	157,660	327,345	348,377

Accounts payable	1,331	3,568	1,922	2,083
Accrued expenses	4,717	4,947	8,917	11,351
Operating lease liabilities, current	316	306	331	336
Notes payable, short-term	4,450	4,511	1,730	1,730
Convertible notes, net of issuance costs	6,979	14,970	-	-
Other liabilities, current	1,231	231	387	441
Total current liabilities	19,024	28,533	13,287	15,941
Earnout liability	24	24	24	24
Canadian government research and development program liability	16,496	16,776	14,876	15,132
Common stock warrants liability	89	167	518	681
Notes payable, long-term	7,654	4,386	0	1,730
Operating lease liabilities	3,449	3,533	3,612	3,689
Other liabilities, long-term	19	30	41	54
Total liabilities	46,755	53,449	32,358	37,251
Common stock, 0.0001 par value, 1,000,000,000 shares authorized 5,499,307 and 5,173,884, issued and outstanding as of march31, 2026 and december31, 2025, respectively (including 50,000 and 50,000, respectively, of sponsor vesting shares)	15	15	15	15
Additional paid-in capital	404,667	402,378	400,253	397,812
Accumulated deficit	-305,475	-287,825	-93,697	-77,315
Accumulated other comprehensive loss	-10,887	-10,357	-11,584	-9,386
Total stockholders equity	88,320	104,211	294,987	311,126
Total liabilities and stockholders equity	135,075	157,660	327,345	348,377

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

MyFinsight

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets